Korean J Anesthesiol.  2013 Feb;64(2):133-137. 10.4097/kjae.2013.64.2.133.

A randomized, double-blind study to evaluate the efficacy of ramosetron and palonosetron for prevention of postoperative nausea and vomiting after gynecological laparoscopic surgery

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. gkjw2000@yahoo.co.kr

Abstract

BACKGROUND
Postoperative nausea and vomiting (PONV) is a common complication after anesthesia and surgery; 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have been considered as a first-line therapy. Ramosetron and palonosetron are more recently developed drugs and have greater receptor affinity and a longer elimination half-life compared with older 5-HT3 receptor antagonists. The purpose of this study was to determine which drug is more effective for preventing PONV between ramosetron and palonosetron.
METHODS
We enrolled 100 patients undergoing gynecological laparoscopic surgery into this study. The subjects were divided into ramosetron group and palonosetron group. The medications were provided immediately before the induction of anesthesia. The occurrence of nausea and vomiting, severity of nausea according to a visual analogue scale, and rescue anti-emetic drug use were monitored immediately after the end of surgery and at 0-6 h, 6-24 h, and 24-48 h post-surgery.
RESULTS
The incidence of vomiting was significantly lower in the palonosetron group than in the ramosetron group during 0-6 h (6% vs 26%, P = 0.012) and 0-48 h (14% vs 34%, P = 0.034). The incidence of nausea and overall PONV, and the use of rescue antiemetic were not significantly different during all time intervals. The severity of nausea was not different between the two groups.
CONCLUSIONS
In conclusion, the incidence of PONV between the ramosetron and the palonosetron group have not shown the difference during 0-48 h, although palonosetron results in a lower incidence of vomiting during 0-6 h post-surgery.

Keyword

Palonosetron; PONV; Ramosetron

MeSH Terms

Anesthesia
Benzimidazoles
Double-Blind Method
Half-Life
Humans
Incidence
Isoquinolines
Laparoscopy
Nausea
Postoperative Nausea and Vomiting
Quinuclidines
Receptors, Serotonin, 5-HT3
Serotonin
Vomiting
Benzimidazoles
Isoquinolines
Quinuclidines
Receptors, Serotonin, 5-HT3
Serotonin

Cited by  2 articles

Efficacy of Palonosetron vs. Ramosetron for the Prevention of Postoperative Nausea and Vomiting: A Meta-Analysis of Randomized Controlled Trials
Min-Soo Kim, Jin Ha Park, Yong Seon Choi, Sang Hun Park, Seokyung Shin
Yonsei Med J. 2017;58(4):848-858.    doi: 10.3349/ymj.2017.58.4.848.

Comparison of the efficacy of ramosetron and palonosetron for prevention of postoperative nausea and vomiting in patients undergoing gynecologic oncology surgery
Hea-Jo Yoon, Young Seok Jee, Young-deuk Kim
Anesth Pain Med. 2016;11(3):264-268.    doi: 10.17085/apm.2016.11.3.264.

Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr